Patent · US Active

Multispecific antibodies against CD40 and CD137

US11084882B2 · kind B2 · utility

4Cited by

0References

11Claims

0Family size

Assignees

GENMAB A/S · DK
BIONTECH SE · DE

Inventors

Isil Altintas · Utrecht, NL
David Satijn · Utrecht, NL
Rik RADEMAKER · Utrecht, NL
Paul Parren · Utrecht, NL
Friederike Gieseke · Mainz, DE
Ugur Sahin · Mainz, DE

Key dates

Filing date	Apr 22, 2020
Grant date	Aug 10, 2021
Priority date	—
Expiry date	Apr 22, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Multispecific antibodies binding to human CD40 and human CD137, methods for preparing such multispecific antibodies, and methods of using such multispecific antibodies for therapeutic or other purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.